LIPANTHYL

This brand name is authorized in Austria, Estonia, Finland, France, Hong Kong SAR China, Lithuania, Poland, Romania, Singapore, South Africa, Tunisia, Turkey.

Active ingredients

The drug LIPANTHYL contains one active pharmaceutical ingredient (API):

1	Fenofibrate UNII U202363UOS - FENOFIBRATE
	Fenofibrate is a fibric acid derivative whose lipid modifying effects reported in humans are mediated via activation of Peroxisome Proliferator Activated Receptor type α (PPARα). Through activation of PPARα, fenofibrate increases lipolysis and elimination of atherogenic triglyceride rich particles from plasma by activating lipoprotein lipase and reducing production of Apoprotein C-III.
	Read more about Fenofibrate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LIPANTHYL Penta Film-coated tablet	MPI, Generic	Health Sciences Authority (SG)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AB05	Fenofibrate	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AB Fibrates
Discover more medicines within C10AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1026593
FI	Lääkealan turvallisuus- ja kehittämiskeskus	143196
FR	Base de données publique des médicaments	62016239, 64563132, 65569444, 69612398
HK	Department of Health Drug Office	44451, 50649, 57155
LT	Valstybinė vaistų kontrolės tarnyba	1003078
PL	Rejestru Produktów Leczniczych	100038040, 100094759, 100104699, 100140749, 100158376, 100274059, 100382116, 100433960, 100451372, 100463035
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68978001, W68978002, W68980001
SG	Health Sciences Authority	11612P, 13615P
TN	Direction de la Pharmacie et du Médicament	5540024, 5873121, 9043532
TR	İlaç ve Tıbbi Cihaz Kurumu	8699817030038, 8699820150259, 8699820150266, 8699820150358
ZA	Health Products Regulatory Authority	30/7.5/0494, 41/7.5/0556